Senior Scientist I/II - Oncology/Immuno-Oncology
(FCRS = is hiring for Senior Scientist I/II - Oncology/Immuno-Oncology in Cambridge (USA). On-site, Senior level, $94k–$174k a year stated. First seen November 4, 2026; open as of November 13, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- (FCRS =
- Where
- Cambridge (USA)
- Arrangement
- On-site
- Level
- Senior
- Pay stated
- $94k–$174k a year
- First seen
- November 4, 2026
- Listed via
- Workday
What the posting says
Job Description Summary Role Type: Onsite Working #LI-Onsite Location: Cambridge, Massachusetts, United States Relocation: Relocation assistance is available for this position Join Novartis Oncology-OIT (Oncology Immune Therapies) group for an exciting opportunity to make a significant impact on cancer immunology. As a key member of our dynamic, multidisciplinary team, you will contribute to the development of groundbreaking therapeutic modalities. Your work will play a crucial role in advancing new therapies and bringing our innovative drugs to patients. Job Description Key…
Read more and apply on (FCRS ='s site
More jobs like this
Pesquisador(a) de Desenvolvimento Galênico (Divulgação para oportunidades futuras) - Divisão de Farmacêuticos Estabelecidos/Centro de Desenvolvimento (EPD) - Rio de Janeiro/RJ
Save to applyScientist II
Save to applyAssociate Research Scientist II
Save to apply2027 R&D Cancer Diagnostics Intern
Save to apply
See all 1,431 Medical Scientists, Except Epidemiologists jobs
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for senior scientist i/ii - oncology/immuno-oncology jobs in Cambridge (USA), new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.